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mRNAs related to coagulant factors (FGB, F5, F8 and F13) was
obviously elevated (P<0.05) in patients with CAD, and the expres-
sion of 2 mRNAs (F5 and F8) among 14 genes was signiﬁcantly up-
regulated (P<0.01) in the AMI groups. (2) In AMI group, the
expression of all mRNAs related to anticoagulant factors was higher
than SAP and control groups, especially, the expression of 3
mRNA(TFPI THBD and SERPINA1) among 8 gens was signiﬁcantly
up-regulated (P<0.01). (3) Compared with control group, the
expression of 3 ﬁbrolysis factor-related mRNAs (SERPINE1 PLAU
and PLAUR) was signiﬁcantly up-regulated (P<0.01) in both groups
AMI and SAP. PLAT mRNA expression was not obviously elevated
and PLG mRNA expression was down-regulated in AMI and SAP
groups.
CONCLUSIONS In this study, there were imbalances in the expression
of mRNAs among coagulation, anticoagulation and ﬁbrinolysis: the
expression of many mRNAs related to coagulant factors and antico-
agulant factors was signiﬁcantly up-regulated, and the expression of
mRNAs related to ﬁbrinolytic system was disordered.
This disequilibrium plays an important role in the progression of
coronary artery disease and arterial thrombosis.GW26-e1456
The Clinical Characteristics, Treatment Status and Their Relations to
Prognosis among Patients Admitted to Tertiary A TCM hospital for Acute
Myocardial Infarction
Xin Hu, Hongxu Liu
Beijing Hospital of Traditional Chinese Medicine, Capital Medical
University
OBJECTIVES To improve clinical quality and patient outcomes in
tertiary A TCM hospitals by providing evidence-base ﬁndings which
obtained through investigation done on patients’ characteristics,
treatments status and prognosis among patients admitted for AMI
during 2013.
METHODS This research is done through analysis of all AMI in-patient
medical records sampled from 29 participated TCM hospitals based on
the diagnosis and treatments guideline for MI issued by Chinese
Medical Association. Cases data were obtain through standardized
CRF that looks into patients’ clinical characteristics, treatment and
prognosis. Data were managed with Microsoft SQL Server. We adopted
descriptive analysis method on general information with SPSS 15.0,
while logistic regression method was employed to conduct multi-
plicity analysis on their related prognosis. Statistical signiﬁcant was
deﬁned as P0.05.
RESULTS Total of 1217 AMI patients were reported to be admitted by
the 29 hospitals which agreed to participate in this research from 1st,
Jan to 31st Dec, 2013. Mean age of the sampled patients was
65.4812.96 years old, among which, 52.42% were over 65 years old,
357(29.55%) were female. 402 patients (34.04%) has been smoking
regularly while 225 (19.50%) has been regular drinker; 61.16%,
32.00% and 34.63% were reported to be associated with HTN, DM
and hyperlipidemia respectively. 439 patients (37.91%) had historical
diagnosis of CHD, 136(12.18%) had MI; 218 patients (18.59%) had
CVD. Meanwhile, 686 cases (59.04%) of STEMI patients were found
among all studied patients; 291 cases (24.87%) were diagnosed with
arrhythmias on admission. The rate of patients with in-hospital
Killip classiﬁcation I, II, III, IV was 54.15%, 23.50%, 8.79%, 7.97%
separately. The most frequently occurred TCM syndromes type of
deﬁcient were: heart-QI deﬁciency (62.37%), heart-YIN deﬁciency
(19.15%), spleen& kidney-QI deﬁciency (10.19%). 1053(86.52%) cases
showed symptoms of blood stasis, while 606 (49.80%) showed
characteristics of phlegm and retained ﬂuid. 536(44.04%) patients
underwent early reperfusion treatments. 1101 (90.47%) and 530
(43.55%) of all cases had received Chinese patent drug intravenously
and orally, 741(60.89%) patients had been given TCM decoction
subscriptions. After eliminated interactions effects, our ﬁnding in-
dicates the following factors has signiﬁcant inﬂuences on the death
rate of studied AMI patients: age, history of diabetes, arrhythmia,
Killip classiﬁcation, TCM clinical manifestations of spleen & kidney-
QI deﬁciency or cold coagulation, early revascularization, oral
Chinese patent drug and TCM decoction.
CONCLUSIONS Findings suggested that the risk factors of in-hospital
mortality including: age65 years, previous medical history of dia-
betes or arrhythmia, Killip classiﬁcationI, TCM clinical manifesta-
tions of spleen& kidney-QI deﬁciency or cold coagulation. Meanwhile,
early reperfusion, oral Chinese patent drug and decoction may have
positively improved short-term prognosis of AMI patients.GW26-e2511
The Correlation Analysis between plasma Cystatin C and the prognosis of
patients with STEMI
Pei Sun, Zhuqin Li
Department of Cardiology, The First Afﬁliated Hospital of Harbin
Medical University, Harbin, China
OBJECTIVES In recent years, the mortality of acute ST segment
Elevation Myocardial Infarction (STEMI) has been increased. Early
assessment for prognosis of STEMI patients is very signiﬁcant.
Although there already have some clinical marker for predicting the
prognosis of STEMI, it’s still dissatisﬁed. Preliminary research showed
that Cystatin C (Cys-C) has the independent prediction value for
STEMI. It seems to be that Cys-C might be involved in atherosclerotic
processes. Another study show that Cys-C and its fragments may also
affect the phagocytic and chemotactic ability of neutrophil, partici-
pates in the inﬂammatory process and regulates inﬂammatory re-
sponses. This study aims to analysis the correlation between plasma
Cys-C and the MACE in STEMI patients.
METHODS Hospitalized patients in coronary care unit of the First
Afﬁliated Hospital of Harbin Medical University from January 2012 to
December 2013 are selected. Patients were diagnosed as STEMI. A total
of 445 patients are selected. Observation indicator is the major adverse
cardiovascular events (MACE) occurrence of those patients in-hospital
and out-hospital. Patients are divided MACE group and non- MACE
group. Statistical analysis is performed. ROC curves of Cys-C, hsCRP,
TnI andCKMBare respectively drawn. Thepredictory value ferMACEas
well as to determine the threshold value. According to the concentra-
tion of plasmaCys-C, patients are divided high concentration group and
low concentration group, and respectively statistical analysis for two
group patients, thus evaluating the correlation among plasma Cys-C
level, the prognosis and adverse events of patients with STEMI.
RESULTS 1. The single factor analysis shows that the average value of
Cys-C in the MACE group is 1.09  0.23 mg/L, while in the non-MACE
group it is 0.82  0.15 mg/L, and there is statistical difference between
two groups (P < 0.0001).
2. Multiple factors analysis shows that OR value of Cys-C is 9.710,
95% CI (5.971, 5.971), indicating that Cys-C is an independent risk
factor of AMI.
3. The area under ROC curve of Cys-C is 0.8431, higher than that of
Hs-CRP (0.6249), TNI (0.544) and CK-MB (0.5569). The best cutoff
values that Cys - C predicting the MACE in STEMI patients is 0.94 mg/
L, the sensitivity was 77.14%, speciﬁcity of 80.85%.
4. With terms in-hospital stay, out-hospital in 1w 6 months and in 7
w12 months, in comparison, the incidence of MACE for the higher
concentration group are 57%, 31.64% and 48.57%, and the lower group
are 17.96%, 2.49% and 7.08% separately, P<0.05; and for terms in-
hospital stay, out-hospital within 1 w 6 months and within 7 w12
months, the total mortality of higher concentration group is 11.5%,
30% and 48.5%, and the lower concentration group, 1.63%, 2.04% and
8.89% separately, P<0.05.
CONCLUSIONS There might be some correlation between the Cys-C
and the MACE in STEMI patients. Cys-C is an independent risk factor
and potential prognosis indicator for MACE that happens both in-
hospital and out-hospital in STEMI patients.
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Mean Platelet Volume is the Predictor of Poor Myocardial Perfusion post
Primary PCI
Jianqiang Xu, Xiangdong Zhao, Chengzhi Lu
Tianjin 1st Central Hospital
OBJECTIVES Mean platelet volume (MPV) is shown to be the pre-
dictor of poor clinical outcome, as well as poor TIMI ﬂow in patients
receiving primary percutaneous coronary intervention (PPCI). But the
correlation of MPV and myocardial perfusion has not been well
demonstrated. So the aim of our study was to investigate the rela-
tionship between pre-intervention MPV and myocardial perfusion
post PPCI in patient with acute ST-segment elevation myocardial
infarction (STEMI).
METHODS Total of 168 consecutive patients from 2012, January to
2014, December suffered from STEMI undergoing PPCI were analyzed
retrospectively. The inclusion criteria were (1) age>65yrs; (2) PPCI was
performed within 12 hours from symptom onset; (3) the infarct-related
artery (IRA) was totally occluded; and (4) post intervention ﬂow was
TIMI 2 or greater. Exclusion criteria were (1) post history of myocardial
infarction, CABG or PCI of IRA; (2) presentation with shock or cardiac
arrest; (3) TIMI 1 or greater ﬂow at IRA at initial angiography; and
